Susquehanna International Group’s Audentes Therapeutics, Inc BOLD Stock Holding History

Susquehanna International Group’s Portfolio BOLD Stock Details BOLD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-88,100	Closed	-$5.27M	–	11366
2019 Q4	$5.27M	Buy	88,100 +44,200	+101%	+$1.66M	﹤0.01%	2899
2019 Q3	$1.23M	Buy	43,900 +7,100	+19%	+$242K	﹤0.01%	5247
2019 Q2	$1.39M	Buy	36,800 +22,800	+163%	+$876K	﹤0.01%	4937
2019 Q1	$546K	Sell	14,000 -6,100	-30%	-$175K	﹤0.01%	6100
2018 Q4	$429K	Sell	20,100 -23,000	-53%	-$593K	﹤0.01%	6324
2018 Q3	$1.71M	Sell	43,100 -55,200	-56%	-$2.06M	﹤0.01%	4258
2018 Q2	$3.76M	Buy	98,300 +34,700	+55%	+$1.29M	﹤0.01%	3081
2018 Q1	$1.91M	Buy	+63,600	New	+$2.15M	﹤0.01%	4001

Susquehanna International Group's BOLD Position: Q1 2020 in Review

Susquehanna International Group sold out of Audentes Therapeutics, Inc (BOLD) in Q1 2020, closing a stake of 69,600 shares — an estimated $4.17M sold.

Susquehanna International Group first reported a position in BOLD in Q2 2019 and held it in 3 quarters. The position peaked at $4.17M in Q4 2019. 0 funds tracked by Wall St. Rank hold BOLD as of Q1 2020.

Susquehanna International Group reported no remaining Audentes Therapeutics, Inc position as of Q1 2020 after selling out during the quarter.
Susquehanna International Group sold 69,600 Audentes Therapeutics, Inc shares in Q1 2020, an estimated $4.17M.
Susquehanna International Group first reported a position in Audentes Therapeutics, Inc in Q2 2019 and held it in 3 quarters.
Susquehanna International Group's Audentes Therapeutics, Inc position peaked at $4.17M in Q4 2019.
0 funds tracked by Wall St. Rank held Audentes Therapeutics, Inc as of Q1 2020.

Based on Susquehanna International Group's 13F filing for Q1 2020, filed 15 May 2020.